Figure - available via license: Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported
Content may be subject to copyright.
Type 2 (lead V2) and type 3 (lead V1) Brugada ECG pattern. Note that both ECG patterns are characterised by the same general shape of the J-ST-T wave, but the ST segment elevation in lead type 3 pattern (lead V1) is slightly less than 0.1mV.
Source publication
The Brugada syndrome (BrS) is a malignant genetically-determined arrhythmic syndrome manifesting as syncope or sudden cardiac death (SCD) in individuals with structurally normal hearts. The diagnosis of the BrS is mainly based on the presence of a spontaneous or Na+-channel blocker induced characteristic electrocardiographic (ECG) pattern (“type 1”...
Similar publications
Background
Brugada syndrome (BrS) is an inherited channelopathy, which is associated with sudden cardiac death due to rapid polymorphic VT or VF. There is no definite consensus regarding the management of asymptomatic patients. Some experts advocate close follow-up; others propose the programmed stimulation for risk stratification. We aimed to eval...
Brugada syndrome (BrS) is an inherited disorder of cardiac ion channels characterized by peculiar ECG findings predisposing individuals to ventricular arrhythmias, syncope, and sudden cardiac death (SCD). Various electrolyte disturbances and ion channels blocking drugs could also provoke BrS ECG findings without genetic BrS. Clinical differentiatio...
Aims
Sudden cardiac death (SCD) is the most common mode of death in childhood hypertrophic cardiomyopathy (HCM). The newly developed HCM Risk-Kids model provides clinicians with individualized estimates of risk. The aim of this study was to externally validate the model in a large independent, multi-centre patient cohort.
Methods and results
A ret...
Background
Brugada syndrome (BrS) is diagnosed in patients with ST‐segment elevation with spontaneous, drug‐induced, or fever‐induced type 1 morphology. Prognosis in type 2 or 3 Brugada electrocardiogram (Br‐ECG) patients remains unknown. The purpose of this study is to evaluate long‐term prognosis in non‐type 1 Br‐ECG patients in a large Japanese...
Background. Brugada syndrome accounts for 4-12% of all sudden deaths worldwide and at least 20% of sudden deaths in patients with structurally normal hearts. Case Report. A 48-year-old female presented to the emergency department after two witnessed syncopal episodes. While awaiting discharge had a third collapse followed by cardiac arrest with sho...
Citations
... Por lo tanto, se debe catalogar como paciente de alto riesgo a todo aquel que presente patrones electrocardiográficos (ECG) característicos del síndrome (13). Sin embargo, cabe resaltar que el estudio electrofisiológico está altamente cuestionado como método de estratificación de riesgo en el síndrome de Brugada (14,15). ...
El síndrome de Brugada (SBr) es una enfermedad cardiaca no estructural que afecta los canales iónicos cardiacos, caracterizado por manifestaciones clínicas como arritmias, taquicardia, síncope y muerte súbita, entre otras. Su diagnóstico es netamente electrocardiográfico, con un patrón altamente sugestivo pero no patognomónico, por lo que existen diagnósticos diferenciales desde el punto de vista electrocardiográfico.Existen tres patrones electrocardiográficos en los pacientes con SBr, de los cuales el tipo I es el patrón más característico. Actualmente, múltiples genes se han relacionado con la presentación de este síndrome, entre los cuales se destaca el gen SCN5A, el más descrito en la literatura. Se conoce que este síndrome es más frecuente en el género masculino; sin embargo, no existen estudios epidemiológicos en Latinoamérica que lo confirmen. Pese a que la investigación alrededor de los mecanismos causales del síndrome ha avanzado, existen varias cuestiones sin resolver, como su enmascaramiento por los signos que producen algunas enfermedades infecciosas causadas principalmente por virus. Por lo tanto, dada la relevancia clínica del tema para el médico general y para el especialista, el objetivo de esta revisión es describir no solo aspectos fisiopatológicos y clínicos de la enfermedad, sino también resaltar casos de pacientes con enfermedades infecciosas quienes posteriormente han sido diagnosticados con el síndrome de Brugada.
... To date, more than 500 only seconds) and disappear naturally. Some patients may be asymptomatic for their life, or symptoms of the disease may include palpitation episodes, syncope, nocturnal agonal respiration, seizures, agitation, loss of bladder control and short-term amnesia (probably due to brain hypoxia) [5,7]. Prolonged VT may resolve into VF and cause cardiac arrest. ...
... VF and SCD can be initial clinical manifestations. It has been reported that BrS is more prevalent in South-East Asia including Japan (present in 15/10,000 inhabitants) com-pared with Western countries (2/10,000) [5,8]. BrS episodes occur more frequently in men, and the risk of SCD in men is 5.5 times greater than in women. ...
... Dynamic variability is characteristic of an ECG in patients with BrS: an ECG could be normal at one time, and at another time point, the type 1 ECG pattern may be observed. Influence of vagal activity (slow heart rate, postprandial status, night-time) and fever (Figure 4) tend to enhance the J-point and ST-segment elevation and type 1 pattern, while physical exercise and catecholamines have a reverse effect[1,5]. According to Mizusawa et al study patients with a fever induced type 1 ECG have an intermediate risk for SCD[13]. ...
... Flecainide, ajmaline, procainamide, disopyramide, propafenone and pilsicainide can be used to unmask suspicious but not diagnostic ECG patterns (e.g. for familial screening). A positive test result is ECG conversion to type 1 pattern [52]. However, prognostic significance of drug induced type 1 pattern is unclear [53]. ...
Major arrhythmias and sudden cardiac death in young and apparently healthy people are usually the first manifestation of cardiac channelopathies (CC). CC include long QT syndrome, short QT syndrome, Brugada syndrome and catecholaminergic polymorphic ventricular tachycardia. Identification and proper management of these diseases is a challenge for the clinical cardiologists, which could benefit from collaboration with geneticists and other physicians due to relevant genetic, molecular, biologic and psychologic implications. Medical awareness of these issues is growing fast as clinical research provides continue update. In this paper, we provide a comprehensive review of CC. The genes associated with CC and their relative role are here illustrated and summarized
... In some people with Brugada syndrome, this pattern is not seen on a standard ECG recording. One common modification to the recording procedure when searching for evidence of the condition is to make additional recordings from 'high' V1 and V2 positions (Naseef et al, 2015). Figure 2(a) shows V1 and V2 in a patient under investigation for unexplained syncope. ...
... One feature of Brugada syndrome that can make the diagnosis challenging is that the pattern may be variable, even changing from day to day in some patients and often not showing the characteristics described (Naseef et al, 2015). The typical appearance is known as a type 1 Brugada pattern; however, other appearances may be seen in which there is a 'saddleback' ST segment with at least 1 mm ST elevation (type 2 pattern) or with less than 1 mm ST elevation (type 3 pattern). ...
Over the course of nearly a century, the 12-lead ECG has proven to be a valuable investigation in the diagnosis and assessment of a wide range of conditions. Like all tests, it has limitations. However, in certain circumstances, and in relation to particular conditions, modification of the standard ECG recording procedure can greatly increase the diagnostic value of the test. The authors look at how modified chest electrode positions and an ajmaline provocation test can unmask Brugada syndrome that is not evident from the standard ECG; how high-resolution signal-averaged ECGs may reveal late ventricular potentials that suggest an increased risk of malignant arrhythmias or the presence of arrhythmogenic right ventricular cardiomyopathy; and how multi-site body surface mapping may prove to be of value, particularly when combined with cardiac imaging, in elucidating the origin, and guiding the curative treatment, of certain arrhythmias.
... La prolongación de las medidas de algunos parámetros electrocardiográficos que reflejan la despolarización y la repolarización ventriculares, como el intervalo QT o el intervalo T PICO -T FINAL (T P-F ), han sido asociadas a un mayor riesgo de presentar AVM en el seguimiento en pacientes con SB 6,7 . Sin embargo, se desconoce cuán variables pueden ser estas mediciones entre un electrocardiograma (ECG) y otro, en estos pacientes. ...
... Se estima que el riesgo es 4 veces mayor que el que presentan los pacientes asintomáticos y 4 veces menor que los pacientes con parada cardíaca abortada. La principal dificultad radica en la diferenciación clínica del síncope de causa cardíaca y no cardíaca 6,7,15 . ...
We present the case of a 55-year-old woman with syncopal episodes and a diagnosis of Brugada syndrome, who spontaneously presented the convex pattern. She received an implantable cardioverter-defibrillator and had a ventricular fibrillation event in the clinical follow-up (106 months). Over this time, 13 electrocardiograms were performed, all of them showing the convex pattern. Moreover, significant variability was observed in wave morphology and electrocardiographic measurements related to depolarization and ventricular repolarization.
... The ECGs of patients with the Brugada type 1 pattern were also examined for features considered to be high risk for malignant arrhythmias, including QRS duration >120 ms in lead V2, 10 corrected QT (QT C ) interval length >460 ms in lead V2, 11 fragmented QRS, 10 11 significant S wave (≥0.1 mV and/ or ≥40 ms) in lead I, 12 and the aVR sign (R wave ≥3 mm or R/q ratio ≥0.75 in lead aVR). 10 13 ...
... 26 There was a high prevalence of risk ECG features among our 14 patients, indicating perhaps a higher risk population compared with other studies. [10][11][12][13] Data from high-prevalence areas, particularly in Southeast Asia, should be pooled with other data in the region to determine the need to change treatment guidelines. To this end, ECG readers need to be trained to recognise the pattern, especially the type 1 pattern, which is the most specific for sudden death. ...
Background
Brugada syndrome is the mechanism for sudden unexplained death. The Brugada ECG pattern is found in 2% of Filipinos. There is a knowledge gap on the clinical outcome of these individuals. The clinical profile and 5-year cardiac event rate of individuals with the Brugada ECG pattern were determined in this cohort.
Methods
This is a sub-study of LIFECARE (Life Course Study in Cardiovascular Disease Epidemiology), a community based cohort enrolling healthy individuals 20 to 50 years old conducted in 2009–2010. ECGs of all enrollees were screened independently by three cardiologists. The prevalence of the coved Brugada ECG pattern was ascertained, and the 5-year cardiac event rate was determined among those individuals with this pattern. The participants were contacted to determine the occurrence of cardiac events, which included syncope, presyncope, seizures, cardiac arrest and unexplained vehicular accidents.
Results
A total of 3072 ECGs were reviewed, and 14 subjects (0.4%) with the coved Brugada ECG pattern were identified. Four had a cardiac event on follow-up at 5 years, but all remained alive. Most of these 14 coved Brugada individuals were healthy and asymptomatic at baseline.
Conclusion
Cardiac events occurred commonly among initially asymptomatic Filipinos with the coved Brugada ECG pattern. Such patients need to be followed up closely.
Purpose of review:
Is to summarise the new contributions toward the understanding of the broad spectrum of manifestations of Brugada syndrome (BrS) during the first years of life. The review encompasses the screening of the asymptomatic patient referred due to family history in one extreme of the spectrum, and also the rare child with early clinical expression of the disease on the opposite side.
Recent findings:
Involve specific features of pediatric BrS including the risk related to a positive family history of sudden cardiac death, the risk of presenting with syncope and the multiple diagnostic challenges of the disease. We included some of the most controversial aspects of the diagnosis and risk stratification, encompassing noninvasive studies (Holter monitors, exercise test, implantable loop recorders, and provocative tests), as well as invasive stratification during the first years of life. Finally, the role and concerns of genetic testing in this age group are commented upon.
Summary:
The main key to minimize overdiagnosis and overtreatment in the young population with a personal and/or family diagnosis of BrS is to perform a systematic but also individualized assessment. Appropriate diagnostic guidelines need to be created and age-specific risk stratification algorithms built for the young patient both with suspected and confirmed BrS.
Introduction
Corrected QT interval (QTc) >460 ms in the right precordial leads has been described as a predictor of malignant ventricular arrhythmias (MVA) in patients with Brugada syndrome (BrS).
Objective
To assess the presence of QTc>460 ms in multiple electrocardiograms (ECGs) during follow-up as a predictor of recurrence of MVA in patients with BrS.
Methods
The study group included 43 patients with BrS and an implantable cardioverter-defibrillator. ECGs were performed serially between June 2000 and January 2017. QT interval was measured and QTc was obtained by Bazett's formula. The sample was divided into three groups: Group 1 (patients with no ECGs with QTc>460 ms); Group 2 (patients with only one ECG with QTc>460 ms); and Group 3 (patients with two or more ECGs with QTc>460 ms).
Results
The following variables were more frequently observed in Group 3: family history of sudden death (p=0.023), previous history of cardiorespiratory arrest (p=0.032), syncope (p=0.039), documented MVA (p=0.002), and proportion of ECGs with coved-type ST interval during follow-up (p=0.002). In Group 3, 67% of BrS patients had events during follow-up, as opposed to only 22% of Group 1 and 14% of Group 2 (Group 1 vs. Group 2, p=0.33015; Group 1 vs. Group 3, p=0.04295; and Group 2 vs. Group 3, p=0.04155).
Conclusions
QTc>460 ms in more than one ECG during follow-up increases the risk of MVA events in patients with BrS.
Introduction
Corrected QT interval (QTc) >460 ms in the right precordial leads has been described as a predictor of malignant ventricular arrhythmias (MVA) in patients with Brugada syndrome (BrS).
Objective
To assess the presence of QTc>460 ms in multiple electrocardiograms (ECGs) during follow-up as a predictor of recurrence of MVA in patients with BrS.
Methods
The study group included 43 patients with BrS and an implantable cardioverter-defibrillator. ECGs were performed serially between June 2000 and January 2017. QT interval was measured and QTc was obtained by Bazett's formula. The sample was divided into three groups: Group 1 (patients with no ECGs with QTc>460 ms); Group 2 (patients with only one ECG with QTc>460 ms); and Group 3 (patients with two or more ECGs with QTc>460 ms).
Results
The following variables were more frequently observed in Group 3: family history of sudden death (p=0.023), previous history of cardiorespiratory arrest (p=0.032), syncope (p=0.039), documented MVA (p=0.002), and proportion of ECGs with coved-type ST interval during follow-up (p=0.002). In Group 3, 67% of BrS patients had events during follow-up, as opposed to only 22% of Group 1 and 14% of Group 2 (Group 1 vs. Group 2, p=0.33015; Group 1 vs. Group 3, p=0.04295; and Group 2 vs. Group 3, p=0.04155).
Conclusions
QTc>460 ms in more than one ECG during follow-up increases the risk of MVA events in patients with BrS.
Background
Risk stratification in Brugada syndrome remains a controversial and unresolved clinical problem, especially in asymptomatic patients with a type 1 ECG pattern. The purpose of this study is to derive and validate a prediction model based on clinical and ECG parameters to effectively identify patients with a type 1 ECG pattern who are at high risk of major arrhythmic events (MAE) during follow-up.
Methods
This study analysed data from 103 consecutive patients with Brugada Type 1 ECG pattern and no history of previous cardiac arrest. The prediction model was derived using logistic regression with MAE as the primary outcome, and patient demographic and electrocardiographic parameters as potential predictor variables. The model was externally validated in an independent cohort of 42 patients.
Results
The final model (Brugada Risk Stratification [BRS] score) consisted of 4 independent predictors (1 point each) of MAE during follow-up (median 85.3 months): spontaneous type 1 pattern, QRS fragments in inferior leads≥3,S wave upslope duration ratio ≥ 0.8, and T peak – T end ≥ 100 ms. The BRS score (AUC = 0.95,95% CI 0.0.92–0.98) stratifies patients with a type 1 ECG pattern into low (BRS score ≤ 2) and high (BRS score ≥ 3) risk classes, with a class specific risk of MAE of 0–1.1% and 92.3–100% across the derivation and validation cohorts, respectively.
Conclusions
The BRS score is a simple bed-side tool with high predictive accuracy, for risk stratification of patients with a Brugada Type 1 ECG pattern. Prospective validation of the prediction model is necessary before this score can be implemented in clinical practice.
